FIELD: medicines. SUBSTANCE: weight percentage of components in medicine is as follows: 0.65-0.75 of Levomycetin, 0.35-0.45 of methyluracil, 0.5-0.7 of lavender oil, 10.0-15.0 of glycerin, 3.0-4.0 of arid lanolin, 10.0-20.0 of drupe fatty oil, 1.0-2.0 of distillated monoglycerides, 0.5-0.8 of stabilizing agent, 0.11-0.12 of Nipagin, 0.11-0.12 of Nipasole, the rest is distillated water. EFFECT: increased epithelial development and healing of festering wounds. 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| WOUND HEALING AGENT | 1998 |
|
RU2160091C2 |
| ANTIMICROBIAL PREPARATION FOR TREATMENT OF INFECTED WOUNDS | 1998 |
|
RU2160092C2 |
| OINTMENT COMPOSITION STIMULATING EPITHELIUM REGENERATION | 1997 |
|
RU2146921C1 |
| PREPARATION FOR TREATMENT OF PATIENT WITH TROPHIC ULCERS | 1998 |
|
RU2146922C1 |
| AGENT FOR TREATMENT OF UNHEALING INFECTED ULCERS AND WOUNDS | 1998 |
|
RU2147240C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH DERMATOSIS | 1997 |
|
RU2146923C1 |
| PREPARATION FOR SUPPURATIVE WOUND TREATMENT AT DIABETES MELLITUS BACKGROUND | 1995 |
|
RU2112548C1 |
| AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
| PHARMACEUTICAL COMPOSITION "OFLOMELID" FOR EXTERNAL APPLICATION IN PYOINFLAMMATORY DISEASE TREATMENT | 2007 |
|
RU2349302C1 |
| WOUND-HEALING AND ANTIBACTERIAL AGENT | 2005 |
|
RU2317818C2 |
